The drug landscape in the nation is increasingly characterized by a pattern toward market consolidation, with a handful of major companies wielding significant influence. These sector giants, often bolstered by extensive distribution networks and strong brand recognition, present a challenging picture for competition and affordable healthcare. W… Read More